Edwards Lifesciences (EW) financials and P/E
Edwards Lifesciences Corporation reported revenue of $1.7B for the quarter to 30 Sep 2026 (Q3 FY26), up 10.5% on a year earlier.
Edwards Lifesciences Corporation fundamentals
- Last close
- 107.15 (13 Nov 2026, Yahoo Finance)
- Market value
- $61.6B (0.57B shares, 10-Q cover 31 Oct 2026, × close)
- P/E, trailing
- 60.5 (107.15 ÷ $1.77 diluted EPS, last four quarters)
- Price to sales
- 9.2 (market value ÷ $6.7B revenue, last four quarters)
- Free cash flow yield
- 2.3% ($1.4B free cash flow, last four quarters ÷ market value)
- Dividend yield
- —
- Net cash
- $4.0B (cash and short-term investments minus debt, 30 Sep 2026)
| Q4 FY25* to 31 Dec 2025 | Q1 FY26 to 31 Mar 2026 | Q2 FY26* to 30 Jun 2026 | Q3 FY26* to 30 Sep 2026 | |
|---|---|---|---|---|
| Revenue | 1569.6 | 1648.6 | 1741.0 | 1715.5 |
| Revenue vs a year earlier | +13.3% | +16.7% | +13.6% | +10.5% |
| Operating income | 151.1 | 477.6 | 513.2 | 299.1 |
| Operating margin | 9.6% | 29.0% | 29.5% | 17.4% |
| Net income | 91.2 | 380.7 | 241.9 | 307.5 |
| Diluted EPS | $0.16 | $0.66 | $0.42 | $0.53 |
| Operating cash flow | 450.9 | 43.8 | 651.9 | 570.3 |
| Capital spending | 97.4 | 64.9 | 66.9 | 63.6 |
| Free cash flow | 353.5 | -21.1 | 585.0 | 506.7 |
| Filing | 10-K, 25 Feb 2026 | 10-Q, 6 May 2026 | 10-Q, 4 Aug 2026 | 10-Q, 4 Nov 2026 |
| FY22 to 31 Dec 2022 | FY23 to 31 Dec 2023 | FY24 to 31 Dec 2024 | FY25 to 31 Dec 2025 | |
|---|---|---|---|---|
| Revenue | 4464.0 | 5010.0 | 5439.5 | 6067.6 |
| Revenue vs a year earlier | -14.7% | +12.2% | +8.6% | +11.5% |
| Operating income | 1498.4 | 1308.9 | 1378.7 | 1264.2 |
| Operating margin | 33.6% | 26.1% | 25.3% | 20.8% |
| Net income | 1521.9 | 1402.4 | 4174.6 | 1073.5 |
| Diluted EPS | $2.44 | $2.30 | $6.97 | $1.83 |
| Operating cash flow | 1218.2 | 895.8 | 542.3 | 1595.2 |
| Capital spending | 244.6 | 253.0 | 252.4 | 260.2 |
| Free cash flow | 973.6 | 642.8 | 289.9 | 1335.0 |
| Filing | 10-K, 28 Feb 2025 | 10-K, 25 Feb 2026 | 10-K, 25 Feb 2026 | 10-K, 25 Feb 2026 |
Balance sheet at 30 Sep 2026 (10-Q): cash and short-term investments $4.6B, debt $598.8M, shareholders’ equity $10.9B.
Free cash flow = operating cash flow − capital spending, as PYE Markets calculates it. * Not filed on its own: the year to date minus the earlier quarters, so per-share figures are approximate. Each column shows the latest filing that reports it. Source: SEC EDGAR XBRL company facts; price: Yahoo Finance daily close. Not investment advice.
Companies of a similar size
PSA (Public Storage), NWG (NatWest Group plc), B (Barrick Mining Corp), ARGX (Argenx SE), LSEGY (London Stock Exchange Group plc), NDAQ (Nasdaq, Inc.), WPM (Wheaton Precious Metals Corp.), IMO (Imperial Oil Ltd), BE (Bloom Energy Corp), TFC (Truist Financial Corp). All symbols.